Acarbose (Libertas Pharma, Inc.)
Welcome to the PulseAid listing for the Acarbose drug offered from Libertas Pharma, Inc.. This alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Libertas Pharma, Inc. |
| NON-PROPRIETARY NAME: | Acarbose |
| SUBSTANCE NAME: | ACARBOSE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-07-27 |
| END MARKETING DATE: | 0000-00-00 |
Acarbose HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acarbose from Libertas Pharma, Inc. |
| LABELER NAME: | Libertas Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2011-07-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51862-210_01b5ea4d-0f75-476d-a53c-c469107a6a3b |
| PRODUCT NDC: | 51862-210 |
| APPLICATION NUMBER: | ANDA090912 |
Other ACARBOSE Pharmaceutical Manufacturers / Labelers:
